Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.
Neuroimmunology: Clostridium-reactive T cells are implicated in the pathogenesis of neuromyelitis optica.
Pediatric Multiple Sclerosis.
Immunology of Multiple Sclerosis.
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis.
Radiation-induced brain injury: low-hanging fruit for neuroregeneration.
Voiding Dysfunction in Multiple Sclerosis.
Long-term Impact of Early MS Treatment with Interferon Beta-1b (IFNB-1b): Clinical, MRI, Employment, and Patient-Reported Outcomes (PROs) at the 11-Year Follow-up of BENEFIT (BENEFIT 11)
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial.
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
Social Support in Relation to Fatigue Symptoms Among Patients with Multiple Sclerosis.
[Immunomodulation and neuroprotection in optic neuritis].
Alkali metals levels in the human brain tissue: Anatomical region differences and age-related changes.
Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
Detailed results from Biogen Idec and AbbVie's pivotal Phase 3 DECIDE study further define the efficacy and safety profile of ZINBRYTA™ (daclizumab high-yield process)
[Prevalence of multiple sclerosis in the Region of Murcia].
A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
Parainfectious longitudinally extensive transverse myelitis associated with varicella-zoster virus.
Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process.
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Safety and tolerability of daclizumab HYP treatment in relapsing-remitting multiple sclerosis: results of the DECIDE study

Pages